Preliminary study on thioredoxin expression in AML cells and apoptosis of AML cells induced by diamide in vitro
- Author:
- No author available
- Journal Title:
- Journal of Leukemia & Lymphoma
- Issue:
- 12
- DOI:
- 10.3760/cma.j.issn.1009-9921.2011.12.006
- Key Word:
- 白血病,实验性;白血病,急性;硫氧还蛋白;二酰胺;细胞凋亡;Leukemia,experiment;Leukemia,acute;Thioredoxin;Diamide;Apoptosis
Abstract： Objective To explore the expression level of thioredoxin (Trx) in acute myeloid leukemia (AML) cells,and its association with clinical features and prognosis,as well as the effects of diamide,an inhibitor of Trx,in inducing AML cells apoptosis.Methods Expression of Trx on AML cells and fresh bone marrow cells from healthy adults were analyzed by Western-blotting. The inhibition of proliferation was measured by MTT assay.The anti-leukemia effect of diamide was observed by morphology and agarose gel electrophoresis.Results 75 ％ (15/20) of AML patients expressed Trx,while no expression was observed in control group.Higher expression level of Trx was associated with higher WBC counts (x2 =9.375,P ＜ 0.05),which suggested that overexpression was associated with leukemogenesis.The inhibition of diamide on AML cells showed time and dose dependent by MTT assay.The IC50 values of diamide at 24 h,48 h and 72 h were 98.26 mg/ml,47.53 mg/ml and 8.34 mg/ml,respectively.After AML cells were treated with diamide,the apoptotic body appeared by morphology,and the typical DNA “ladder” bands were confirmed by agarose gel electrophoresis.Conclusion Trx expression level in AML cells is significantly higher than that of control group.Diamide inhibites the proliferation of AML cells by inducing apoptosis,which might be a potential agent for AML.
- [1]Masutani H,Yodoi J,Nakamura H,etc.Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2.[J].2010,127(3).
- [2]Marks PA.Thioredoxin in cancer--role of histone deacetylase inhibitors.[J].2006,16(6).
- [3]Yuan Y,Lau WB,Christopher TA,etc.Thioredoxin glycation: A novel posttranslational modification that inhibits its antioxidant and organ protective actions.[J].2010,49(3).
- [4]Yodoi,Kwon YW,Mochizuki M.Thioredoxin regulates cell cycle via the ERK1/2-cyclin D1 pathway.[J].2009,11(12).
- [5]Cuaz Perolin C,Imen JS,Billiet L.The regulated in development and DNA damage response 2 (REDD2) gene mediates human monocyte cell death through a reduction in thioredoxin-1 expression.[J].2009,46(10).
- [6]Arai RJ,Masutani H,Augusto O,etc.Thioredoxin-1 promotes survival in cells exposed to S-nitrosoglutathione: Correlation with reduction of intracellular levels of nitrosothiols and up-regulation of the ERK1/2 MAP Kinases.[J].2008,233(2).
- [7]Zhong W,Shan W,Zhao R,etc.Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression.[J].2010,49(12).
- [8]Holmgren A,Lu J.Thioredoxin and thioredoxin reductase: current research with special reference to human disease.[J].2010,396(1).
- [9]Hoshino Y,Okuyama H,Nakamura H.Thioredoxin 1 delivery as new therapeutics.[J].2009,61(4).
- [10]Maulik N,Das DK.Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions.[J].2008,1780(11).
- [11]Belisario MA,Gallotta D,Nigro P,etc.Inhibition of the thioredoxin system is a basis for the antileukemic potential of 13-hydroxy-15-oxo-zoapatlin.[J].2008,45(6).
- [12]Ichijo H,Fujino G,Takeda K,etc.Thioredoxin and protein kinases in redox signaling.[J].2006,16(6).
- [13]Holmgren A.Thioredoxin[J].1985.
- [14]T C, LAURENT,E C, MOORE,P, REICHARD.Enzymatic Synthesis of Deoxyribonucleotides. IV. Isolation and Characterization of Thioredoxin, the Hydrogen Donor from Escherichia Coli B.[J].1964,239.